SCHEMBL10744909

SCHEMBL10744909

O=c1c2ccccc2[se]n1-c1nnc2cc([N+](=O)[O-])ccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.42
▸ TDO2 P48775 1/20 0.42
▸ IDO2 Q6ZQW0 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HTT P42858 2/20 0.42
▸ METAP2 P50579 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ QSOX1 O00391 1/20 0.42
▸ RGS12 O14924 1/20 0.42
▸ PMM2 O15305 1/20 0.42
▸ PLIN1 O60240 1/20 0.42
▸ GMNN O75496 1/20 0.42
▸ BBOX1 O75936 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYBB P04839 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10746433 0.87 KMT2A (0.38) IDO1TDO2IDO2ALDH1A1HTT
SCHEMBL10749275 0.81 METAP2 (0.54) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL10749509 0.81 METAP2 (0.51) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL10954133 0.81 METAP2 (0.46) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL10746865 0.81 METAP2 (0.55) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL5916836 0.76 METAP2 (0.49) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL5916565 0.76 RAB9A (0.54) ALDH1A1HTTMEN1CYP3A4MAPT
SCHEMBL10501892 0.74 METAP2 (0.66) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL10501872 0.74 METAP2 (0.62) IDO1ALDH1A1HTTMETAP2KDM4E
SCHEMBL10502027 0.73 METAP2 (0.62) METAP2MPIPHOSPHO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
US-4550168-A Benzisoselenazolones and a process for the treatment of inflammatory diseases A. NATTERMANN & CIE GMBH (DE) 1985-10-29 — — US disclosed
EP-0100899-A2 Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1984-02-22 — — EP disclosed
Send feedback